Erkan Baloglu
- Oncology top 2%
- Cancer-related Molecular Pathways 20
- PARP inhibition in cancer therapy 8
- Cancer Treatment and Pharmacology 7
- Geriatrics and Gerontology top 5%
- Hematology top 5%
- Acute Myeloid Leukemia Research 8
- Multiple Myeloma Research and Treatments 5
- Molecular Biology top 5%
- Nuclear Structure and Function 26
- RNA Research and Splicing 12
- Physiology top 5%
-
- Microtubule and mitosis dynamics 5
- Co-authors
- David G. I. KingstonWilliam SenapedisYosef LandesmanSharon ShachamDilara McCauleyMichael KauffmanClaudio FestucciaGiovanni Luca Gravina
- Partner nations
- United StatesSingaporeBelgium
In The Last Decade
Erkan Baloglu
83 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 101
- Oncology 1.2k
- Geriatrics and Gerontology 123
- Hematology 346
- Molecular Biology 1.9k
- Physiology 105
Countries citing papers authored by Erkan Baloglu
This map shows the geographic impact of Erkan Baloglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkan Baloglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkan Baloglu more than expected).
Fields of papers citing papers by Erkan Baloglu
This network shows the impact of papers produced by Erkan Baloglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkan Baloglu. The network helps show where Erkan Baloglu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erkan Baloglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2021 | 16 | |
| 3 | 2019 | 30 | |
| 4 | 2019 | 24 | |
| 5 | 2019 | 4 | |
| 6 | 2018 | 78 | |
| 7 | 2018 | 28 | |
| 8 | 2018 | 3 | |
| 9 | 2017 | 30 | |
| 10 | 2017 | 10 | |
| 11 | 2017 | 17 | |
| 12 | 2017 | 57 | |
| 13 | 2016 | 115 | |
| 14 | 2016 | 53 | |
| 15 | 2016 | 74 | |
| 16 | 2015 | 29 | |
| 17 | 2015 | 31 | |
| 18 | 2014 | 99 | |
| 19 | 2002 | 158 | |
| 20 | 2001 | 15 |
About Erkan Baloglu
Erkan Baloglu is a scholar working on Oncology, Hematology and Molecular Biology, having authored 85 papers that have together received 3.0k indexed citations. Recurring topics across this work include Nuclear Structure and Function (26 papers), Cancer-related Molecular Pathways (20 papers), RNA Research and Splicing (12 papers), PARP inhibition in cancer therapy (8 papers), Acute Myeloid Leukemia Research (8 papers), Cancer Treatment and Pharmacology (7 papers), Multiple Myeloma Research and Treatments (5 papers) and Microtubule and mitosis dynamics (5 papers). The work is most often cited by research in Oncology (1.2k citations), Geriatrics and Gerontology (123 citations) and Hematology (346 citations). Erkan Baloglu has collaborated with scholars based in United States, Singapore and Belgium. Frequent co-authors include David G. I. Kingston, William Senapedis, Yosef Landesman, Sharon Shacham, Dilara McCauley, Michael Kauffman, Claudio Festuccia, Giovanni Luca Gravina, Prakash G. Jagtap and Marsha Crochiere. Their work appears in journals such as Cancer Research, Blood, Oncotarget, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.